Resources

Selected
  • Systematic reviews (SYSVAC)
Type of publications
Regions
Diseases
Vaccine topics
Target population
Publication date

3152 results found

2023 ∙ Rosca, E. C. Bilavu, R. Cornea, A. Simu, M.

Chorea following SARS-CoV-2 infection and vaccination: a systematic review of reported cases

  • All age groups
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Alijanzadeh, D. Soltani, A. Afra, F. Salmanpour, F. Loghman, A. H. Samieefar, N. Rezaei, N.

Clinical characteristics and prognosis of temporary miller fisher syndrome following COVID-19 vaccination: a systematic review of case studies

  • Adults
  • Older adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Alotaibi, N. M. Alroqi, S. Alharbi, A. Almutiri, B. Alshehry, M. Almutairi, R. Alotaibi, N. Althoubiti, A. Alanezi, A. Alatawi, N. Almutairi, H. Alhmadi, M. Almutairi, R. Alshammari, M.

Clinical Characteristics and Treatment Strategies for Group B Streptococcus (GBS) Infection in Pediatrics: A Systematic Review

  • All age groups
  • Pregnant women
  • Parents/caregivers
  • Healthcare workers
  • Streptococcus group B
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Tayebi, A. H. Samimisedeh, P. Jafari Afshar, E. Ayati, A. Ghalehnovi, E. Foroutani, L. Abbasi Khoshsirat, N. Rastad, H.

Clinical features and outcomes of Myasthenia Gravis associated with COVID-19 vaccines: A systematic review and pooled analysis

  • Adults
  • Older adults
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Zhou, H. Ye, Q.

Clinical Features of COVID-19 Vaccine-Associated Autoimmune Hepatitis: A Systematic Review

  • Adults
  • Older adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Yuan, Z. Shao, Z. Ma, L. Guo, R.

Clinical Severity of SARS-CoV-2 Variants during COVID-19 Vaccination: A Systematic Review and Meta-Analysis

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Chenchula, S. Amerneni, K. C. Ghanta, M. K. Padmavathi, R. Chandra, M. B. Adusumilli, M. B. Chavan, M. Mudda, S. Gupta, R. Lakhawat, B.

Clinical virology and effect of Covid-19 vaccination and monoclonal antibodies against highly infectious SARS- CoV-2 omicron sub variant BF.7 (BA.5.2.1.7): A systematic review

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Fortier, L. M. Smith, K. L. Ina, J. G. Sinkler, M. A. Calcei, J. G. Salata, M. J. Gillespie, R. Voos, J. E.

Common Characteristics of Shoulder Injury Related to Vaccine Administration (SIRVA) Following COVID-19 Vaccination: A Comprehensive Systematic Review

  • Adults
  • Older adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Oketch, Sandra Y. Ochomo, Edwin O. Orwa, Jeniffer A. Mayieka, Lilian M. Abdullahi, Leila H.

Communication strategies to improve human papillomavirus (HPV) immunisation uptake among adolescents in sub-Saharan Africa: a systematic review and meta-analysis

  • Africa
  • Adolescents
  • Parents/caregivers
  • Healthcare workers
  • Human papillomavirus (HPV)
  • Acceptance
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
2023 ∙ Liyew, A. M. Gilmour, B. Clements, A. C. A. Alene, K. A.

Comparative effectiveness of interventions for preventing tuberculosis: systematic review and network meta-analysis of interventional studies

  • All age groups
  • Tuberculosis
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
Loading...